Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Naofumi Eriguchi is active.

Publication


Featured researches published by Naofumi Eriguchi.


The Annals of Thoracic Surgery | 2003

Modified Dumon stent for the treatment of a bronchopleural fistula after pneumonectomy

Kohsuke Tayama; Naofumi Eriguchi; Yasuhiko Futamata; Hiroshi Harada; Atsushi Yoshida; Akira Matsunaga; Masahiro Mitsuoka

We describe the case of a 72-year-old man in whom a bronchopleural fistula developed after induction chemotherapy followed by right pneumonectomy for lung cancer. Resuturing of the right main bronchial stump, endoscopic treatment, and repair using a latissimus dorsi muscle flap were not effective. Consequently we placed a modified Dumon stent in the carina, which effectively closed the stump.


Surgery Today | 2001

Unusual liver carcinomas with sarcomatous features: analysis of four cases.

Naofumi Eriguchi; Shigeaki Aoyagi; Koji Okuda; Masao Hara; Shuichi Fukuda; Tsuyoshi Tamae; Masaharu Ohdo; Naomitsu Kanazawa; Masahiro Kawabata; Takahito Kodama; Kazunori Nishimura; Shigeru Hamada

Abstract We recently examined the clinicopathological and immunohistochemical features of four cases of primary hepatic carcinoma with sarcomatoid elements. Three of the four patients had associated ordinary hepatocellular carcinoma (HCC) and one had a sarcomatoid carcinoma with no apparent elements of HCC. The presenting symptoms were high fever and hypochondralgia in three patients, and right hypochondralgia without a high fever in one. The preoperative diagnoses were liver abscess in two patients, HCC in one, and cholangioma in one. Preoperative imaging showed necrotic change or abscess formation in the tumors. The sarcomatous elements showed a positive reaction to vimentin in three patients, but the ordinary HCC cells did not. Macroscopically, the tumors appeared as a single nodule with pericapsular growth. The prognoses of these patients were poor due to the early development of intrahepatic or distal metastases. We conclude that symptoms such as a high fever or hypochondralgia are characteristics of these tumors and that they may be histogenetically derived from a dedifferentiation of HCC, although no elements of HCC were found in one of our cases.


Surgery Today | 2000

Synchronous or metachronous double cancers of the pancreas and other organs: Report on 12 cases

Naofumi Eriguchi; Shigeaki Aoyagi; Masao Hara; Koji Okuda; Tsuyoshi Tamae; Shuichi Fukuda; Kotaro Hashino; Shinji Sato; Kei Fujiki; Satoshi Furukawa; Atsuo Jimi

Pancreatic carcinoma carries a poor prognosis, especially invasive ductal carcinoma of the pancreas. This retrospective study describes the results of the treatment and prognosis for double cancers in which cancer of the pancreas was associated with malignancies in other organs in 12 patients who were diagnosed and treated at Kurume University Hospital. The patients included 4 women and 8 men, with an average age of 67 years. Of the 12 tumors, 7 were metachronous pancreatic cancers which occurred after resections of other organ malignancies. Five patients had synchronous double cancers, one of whom was diagnosed to have gastric cancer on admission. Two other patients of this group were diagnosed to have lung cancer, while the remaining 2 patients suffered from colon cancer. By the time pancreatic cancer was diagnosed, gastrectomies had been performed in 7 patients for either gastric cancer or ulcers. In addition, one patient underwent a hysterectomy for uterine carcinoma and another received a low anterior resection for rectal carcinoma. Four of 5 patients in the synchronous group had nonresectable tumors and a palliative bypass operation was performed in 2 of these patients. Six patients who had metachronous double cancers died because of pancreatic cancer recurrence or metastases. We conclude that the prognosis of double cancers, where cancer of the pancreas is associated with other organ malignancies, primarily depends on the prognosis of the pancreatic carcinoma, and the present study suggests the necessity of long-term follow-up examinations for gastrectomy patients in order to make an early diagnosis of pancreatic cancer.


Pathology Research and Practice | 2011

A case of IgG4-related sclerosing mesenteritis

Yoriko Nomura; Yoshiki Naito; Naofumi Eriguchi; Toru Kume; Noriaki Itai; Hirokuni Sonoda; Shigeru Hayashida; Shigetoshi Naito; Hisanori Naito; Makiko Yasumoto; Jun Akiba; Hisafumi Kinoshita; Hirohisa Yano; Masayoshi Kage

IgG4-related disease has been recognized as a systemic syndrome characterized by mass-forming lesions with lymphoplasmacytic infiltration and sclerosis. This disease has been identified in various sites, including the pancreas, retroperitoneum, lung, head, and neck. Herein we report a case of IgG4-related sclerosing mesenteritis. An 82-year-old woman was admitted to our hospital due to persistent abdominal pain. Abdominal computed tomography demonstrated a solitary mass with a maximal diameter of 11.7cm in mesentrium of the small intestine. On her laboratory examination, only C-reactive protein level was elevated. Although the pre-operative diagnosis was indefinite, she underwent ileocecectomy. Grossly, an elastic soft mass with foci of hemorrhage was seen in the mesentrium. Microscopically, the lesion was composed of fibroblastic or myofibroblastic spindle cells with abundant stromal fibrosis and inflammatory infiltrate, such as lymphocytes and plasma cells accompanied by lymphoid follicles with a germinal center. Obstructive phlebitis was observed. Immunohistochemically, numerous IgG4-positive plasma cells were observed, and the IgG4/IgG ratio was 75.9%. The serum level of IgG4 examined at post-operation was high. These findings suggested that this lesion was consistent with IgG4-related sclerosing mesenteritis.


Surgery Today | 2003

Signet-Ring Cell Carcinoma of the Ampulla of Vater : Report of a Case

Naofumi Eriguchi; Shigeaki Aoyagi; Atsuo Jimi

An 83-year-old man was admitted to our hospital complaining of general fatigue, fever, and obstructive jaundice. Percutaneous transhepatic bile duct drainage was performed. Gastroduodenal fiberscopy revealed carcinoma of the ampulla of Vater, and early gastric cancer was suspected. A pancreatoduodenectomy with lymph node dissection was performed. Although a biopsy specimen from the gastric lesion was suspected to be well-differentiated adenocarcinoma, no cancerous lesion was found in a specimen resected from the stomach. The histopathologic findings of the ampullary lesion were compatible with a diagnosis of signet-ring cell carcinoma. This is a rare lesion, and a review of the literature revealed only three previous similar cases.


Journal of Gastroenterology | 1998

ILEO-ABDOMINAL WALL FISTULA CAUSED BY DIVERTICULUM OF THE ILEUM

Naofumi Eriguchi; Shigeaki Aoyagi; Toshimichi Nakayama; Yasunori Emi; Motonori Saku; Kouji Yoshida

Abstract: We report a very rare case of ileo-abdominal fistula caused by penetration of the ileal diverticulum. Small bowel diverticulosis is generally considered to be an innocuous condition. In this report, we describe a case of ileal diverticulitis associated with an abdominal wall abscess.


Japanese Journal of Cancer Research | 1992

The Inhibitory Effect of the Combination of Antineoplaston A-10 Injection with a Small Dose of cis-Diamminedichloroplatinum on Cell and Tumor Growth of Human Hepatocellular Carcinoma

Hideaki Tsuda; Shigetaka Sugihara; Hiroyuki Nishida; Hiroshi Hara; Naofumi Eriguchi; Kiyoshi Ishii; Kiyoshi Sasaki; Shinsuke Yoshimura; Noriho Tanaka

The inhibitory effects of a combination of Antineoplaston A‐10 Injection with a small dose of m‐diamminedichloroplatinum (CDDP) on cell and tumor growth was tested in in vitro and in vivo settings. A human hepatocellular carcinoma cell line (KIM‐1) was used for the cell growth and transplanted tumor growth studies. In the cell growth study, one‐hour exposure of KIM‐1 cells to CDDP in the medium at concentrations of 0.5, 1.0, and 2.0 μg/ml inhibited cell growth dose‐dependently. Continuous exposure of cultured cells to Antineoplaston A‐10 Injection at concentrations of 4, 6, and 8 mg/ml also inhibited tumor growth dose‐dependently. The combination of 0.5 μg/ml CDDP and 6 mg/ml A‐10 Injection inhibited cell growth more than did each agent individually. Electron microscopic study showed well‐maintained organelle structures in Antineoplaston A‐10 Injection‐treated cells compared to CDDP‐treated cells. α‐Fetoprotein (AFP) production by 104 cells in 48 h increased in the A‐10 Injection‐treated and A‐10 Injection + CDDP‐treated groups as the concentration of these agents increased. In the tumor growth study, daily administration of Antineoplaston A‐10 Injection 75 mg with once a week administration of 20 μg of CDDP for 5 weeks inhibited transplanted tumor growth in athymic mice after 33 days of treatment, while administration of 75 mg of A‐10 Injection or 20 or 60 μg of CDDP alone showed no significant inhibition of tumor growth.


Surgery Today | 2000

Insulinoma occurring in association with fatty replacement of unknown etiology in the pancreas: report of a case.

Naofumi Eriguchi; Shigeaki Aoyagi; Masao Hara; Hiroyasu Imayama; Koji Okuda; Kotaro Hashino; Naomitsu Kanazawa; Tsuyoshi Tamae; Shuichi Fukuda; Atsuo Jimi

A 66-year-old woman with a 10-year-history of diabetes mellitus was admitted to our hospital for investigation of several recent attacks of hypoglycemia. Her fasting blood glucose level was very low, at 30–40 mg/dl, and abdominal ultrasonography and computed tomography revealed a tumor in the pancreatic tail with fatty changes. Endoscopic retrograde cholangiopancreatography revealed absence of the main pancreatic duct from the body to tail of the pancreas. Abdominal angiography showed a hypervascular tumor stain in the pancreas, and percutaneous transhepatic portal vein sampling demonstrated a step-up of immunoreactive insulin levels in the splenic vein. Based on these clinical findings, we made a preoperative diagnosis of an insulinoma accompanied by fatty changes in the pancreatic body and tail. During laparotomy for the insulinoma, fat tissue was identified in the anatomic location of the pancreatic body and tail, and resected. Pathological examination of the resected specimen revealed a number of Langerhans islets in the adipose tissue, and an islet cell tumor with fatty replacement of the pancreatic tissue around the tumor. The insulinoma was found not to have caused obstruction of the main pancreatic duct. We present herein a rare case of an insulinoma that developed in the pancreas, and was associated with fatty replacement of unknown etiology.


Surgery Today | 1999

Nonfunctioning Islet Cell Carcinoma of the Pancreas: An Evaluation of Seven Patients Who Underwent Resection Followed by Long-Term Survival

Naofumi Eriguchi; Shigeaki Aoyagi; Masao Hara; Shuichi Fukuda; Eiji Tanaka; Mitsuo Hashimoto

Islet cell carcinoma of the pancreas is a rare, indolent malignancy associated with a higher resectability rate and better survival than ductal carcinoma. This retrospective study presents the results of surgical treatment for nonfunctioning islet cell carcinoma of the pancreas in seven patients diagnosed and treated at Kurume University Hospital. There were two men and five women, with an average age of 54 years. Of the five tumors, four were located in the head of the pancreas, and the other three tumors were located in the body or tail of the pancreas. Epigastric pain was frequently the primary clinical symptom. By the time of diagnosis, four of the patients had regional disease, one of whom had lymph node and liver metastases, and one, liver metastases. Another patients was found to have lymph node metastases intraoperatively. Only one of the patients died of recurrent cancer, 21 years after the original operation. All of the patients who had liver metastases at the time of initial surgical treatment are now living at home. Thus, we conclude that nonfunctioning islet cell carcinomas are slow-growing tumors with a good prognosis if the main tumors and metastatic lesions are removed.


Surgery Today | 2001

Malignant Sarcomatoid Tumor of the Liver: Report of a Case

Naofumi Eriguchi; Shigeaki Aoyagi; Masao Hara; Koji Okuda; Shuichi Fukuda; Tsuyoshi Tamae; Naomitsu Kanazawa

Abstract A 65-year-old man was referred to our hospital for treatment of a liver tumor. Abdominal ultrasonography (US) demonstrated a low echoic mass in the S2–S4 region of the liver, which was confirmed by abdominal computed tomography (CT). In the delayed phase of angio-CT, the inside of the mass was not enhanced. Abdominal angiography showed a hypovascular area in the liver. An extended left lobectomy was performed. Macroscopically, the tumor was 9.5 × 9.5 cm in size, and on cross section, it was white and clearly demarcated from the surrounding tissue. Microscopic observation of hematoxylin–eosin-stained specimens did not show any glandular or trabecular formation. Histologically, there was diffuse proliferation of atypical spindle cells that had hyperchromatic, short, spindle-shaped nuclei, and pale cytoplasm with poor intercellular adhesion. The nontumorous tissue was almost normal with no sign of cirrhosis. Immunohistochemical examination showed that the spindle cells were positive for vimentin and cytokeratins (AE1/AE3, CAM 5.2), but negative for all other markers. The final diagnosis was a sarcomatoid carcinoma, the origin of which was not able to be confirmed immunohistochemically. This case of a primary hepatic tumor composed of malignant cells with sarcomatous features is described, and the immunohistochemical findings are discussed.

Collaboration


Dive into the Naofumi Eriguchi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge